Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs

QJM: An International Journal of Medicine

Volumn 106, Issue 12, 2013, Pages 1111-1117

  Yamamoto, T ^a   Kawsar, A ^b   Ramsey, J ^c   Dargan, P I ^a,d   Wood, D M ^a,d  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; 4 METHYLETHCATHINONE; 4' METHYLMETHCATHINONE; 5 IODO 2 AMINOINDANE; CAFFEINE; CALCIUM CARBONATE; CANNABINOID RECEPTOR AGONIST; CANNABIS; CHLOROQUINE; COCAINE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FOLIC ACID; GAMMA BUTYROLACTONE; IBUPROFEN; KETAMINE; LACTOSE; METHAMPHETAMINE; N BENZYLPIPERAZINE; NEVIRAPINE; NICARDIPINE; NICOTINAMIDE; PARA METHOXY N METHYLAMPHETAMINE; PARACETAMOL; PIPERAZINE DERIVATIVE; RECREATIONAL DRUG; SILDENAFIL; TOLTERODINE; UNCLASSIFIED DRUG;

ARTICLE; CONTENT ANALYSIS; DANCING; DRUG DATABASE; DRUG MONITORING; DRUG USE; HARM REDUCTION; HERBAL MEDICINE; HUMAN; INFRARED SPECTROSCOPY; LEGAL ASPECT; LIQUID; MALE; MALE HOMOSEXUAL; MICROCAPSULE; POLICE; POWDER; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECREATION; TABLET;

CAPSULES; DANCING; DRUG UTILIZATION; HOMOSEXUALITY; HUMANS; LONDON; POWDERS; SOLUTIONS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TABLETS; WASTE DISPOSAL FACILITIES;

EID: 84888985407     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hct183     Document Type: Article

References (35)

1. Home Office Statistical Bulletin. Drug Misuse Declared: Findings from the 2011/12 British Crime Survey for England and Wales (2nd Edition) July 2012 [online] 2012. http://www.homeoffice.gov.uk/publications/science-research-statistics/research-statistics/crime-research/drugs-misuse-dec-1112/drugs-misuse-dec-1112-pdf?view=Binary (20 August 2013, date last accessed).
2. Binks S, Hoskins R, Salmon D, Benger J. Prevalence and healthcare burden of illegal drug use among emergency department patients. Emerg Med J 2005; 22:872-3.
3. Morgan CJA, Noronha LA, Muetzelfeldt M, Fielding A, Curran HV. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users. J Psychopharmacol 2013; 27:497-506.
4. Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr 1997; 167:17-36.
5. European Monitoring Centre for Drugs and Drug Addiction Annual Report 2012. http://www.emcdda.europa.eu/attachements.cfm/att_190854_EN_TDAC12001ENC_.pdf (20 August 2013, date last accessed).
6. United Nations Office on Drugs and Crime. World Drug Report 2012. http://www.unodc.org/unodc/en/data-and-analysis/WDR-2012.html (7 July 2013, date last accessed).
7. The Mixmag/Guardian Drugs Survey 2012. http://www.mixmag.net/drugssurvey (20 August 2013, date last accessed).
8. Wood D, Hunter L, Measham F, Dargan PI. Limited use of novel psychoactive substances in South London nightclubs. QJM 2012; 105:959-64.
9. European Commission. Eurobarometer Special Surveys-European Week for Drug Abuse Prevention. http://ec.europa.eu/public_opinion/archives/ebs/ebs_067_en.pdf (20 August 2013, date last accessed).
10. Wood DM, Davies S, Calapis A, Ramsey J, Dargan PI. Novel drugs-novel branding. QJM 2012; 105:1125-6.
11. Brandt SD, Sumnall HR, Measham F, Cole J. Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test Anal 2010; 2:377-82.
12. Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ. Content of ecstasy in the Netherlands:1993-2008. Addiction 2009; 104:2057-66.
13. Brunt TM, Rigter S, Hoek J, Vogels N, van Dijk P, Niesink RJ. An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. Addiction 2009; 104:798-805.
14. Turner CF, Villarroel MA, Rogers SM, Eggleston E, Ganapathi L, Rpman AM, et al. Reducing bias in telephone survey estimates of the prevalence of drug use: a randomised trial of telephone audio-CASI. Addiction 2005; 100:1432-44.
15. Ventura M, Pichini S, Ventura R, Leal S, Zuccaro P, Pacifici R, et al. Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes. Ther Drug Monit 2009; 31:277-80.
16. Ramsey JD, Butcher MA, Murphy MF, Lee T, Johnston A, Holt DW. A new method to monitor drugs at dance venues. BMJ 2001; 323:603.
17. Kenyon SL, Ramsey JD, Lee T, Johnston A, Holt DW. Analysis for identification in amnesty bin samples from dance venues. Ther Drug Monit 2005; 27:793-98.
18. Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, et al. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gammabutyrolactone (GBL) and 1,4-butanediol (1,4BD). QJM 2008; 101:23-9.
19. LADPF. Drugs at the door - Guidance for venues and staff on handling drugs. http://www.cityoflondon.gov.uk/services/adult-health-wellbeing-and-social-care/drugs-and-alcohol/substance-misuse-partnership/Documents/SS_LDAPF_drugsatthedoor2011.pdf (20 August 2013, date last accessed).
20. TICTAC Communications Ltd, St Georges University of London, Cranmer Terrace, SW17 0RE. http://www.tictac.org.uk/ (20 August 2013, date last accessed).
21. Winstock AR, Wolff K, Ramsey J. Ecstasy pill testing: harm minimization gone too far? Addiction 2001; 96:1139-48.
22. WHO Traditional Medicine. Definitions. www.who.int/medicines/areas/traditional/definitions/en/index.html (20 August 2013, date last accessed).
23. Measham F, Wood DM, Dargan PI, Moore K. The rise in legal highs: prevalence and patterns in the use of illegal drugs and first- and second generation 'legal highs' in South London gay dance clubs. J Subs Use 2011; 16:263-72.
24. Archer JR, Dargan PI, Hudson S, Davies S, Puchnareqicz M, Kicman AT, et al. Taking the Pissoir - a novel and reliable way of knowing what drugs are being used in nightclubs. J Subs Use 2013; 00:1-5.
25. Wood DM, Measham F, Dargan PI. 'Our favourite drug': prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. J Subs Use 2012; 17:91-7.
26. Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal 2011; 3:89-96.
27. The fight against food adulteration. http://www.rsc.org/education/eic/issues/2005mar/thefightagainstfoodadulteration.asp (20 August 2013, date last accessed).
28. Winstock A, Mitcheson L, Marsden J. Mephedrone: still available and twice the price. The Lancet 2010; 376:1537.
29. Smith Z, Moore K, Measham F. MDMA powder, pills and crystal: the persistence of ecstasy and the poverty of policy. Drugs and Alcohol Today 2009; 9:13-19.
30. Wood DM, Stribley V, Dargan PI, Davies S, Holt DW, Ramsey J. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK. Emerg Med J 2011; 28:764-5.
31. Vevelstad M, Oiestad EL, Middelkoop G, Hasvold I, Lilleng P, Delaveris GJ. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Forensic Sci Int 2012; 219:151-7.
32. Lurie Y, Gopher A, Lavon O, Almog S, Sulimani L, Bentur Y. Severe paramethoxymethamphetaine (PMMA) and paramethoxyamphetamine (PMA) outbreak in Israel. Clin Toxicol (Phila) 2012; 50:39-43.
33. Elie MP, Elie LE, Baron MG. Keeping pace with NPS releases: fast GC-MS screening of legal high products. Drug Test Anal 2013; doi:10.1002/dta.1434 [Epub 7 January 2013].
34. EMCDDA-Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA. http://www.emcdda.europa.eu/publications/implementation-reports/2011 (20 August 2013, date last accessed).
35. Ayres TC, Bond JW. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill) health. Legal highs or illegal highs? BMJ Open 2012; 2:e000977.